/
Medical Research Council  Human Genetics Unit Medical Research Council  Human Genetics Unit

Medical Research Council Human Genetics Unit - PowerPoint Presentation

celsa-spraggs
celsa-spraggs . @celsa-spraggs
Follow
426 views
Uploaded On 2017-09-24

Medical Research Council Human Genetics Unit - PPT Presentation

MRC Institute of Genetics and Molecular Medicine wwwigmmacuk GS Symposium 6 th May 2016 Caroline Hayward Quantitative Trait Genetics in Health and Disease 20032 GSSFHS DNA samples genotyped and passed quality control with Illumina OmniExpress Exome chip at WTCRF Genetics Core lab ID: 590421

family data amp health data family health amp study ibd alleles sharing parent genetics genetic research analyses genotyped europe

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Medical Research Council Human Genetics..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Medical Research Council Human Genetics UnitMRC Institute of Genetics and Molecular Medicinewww.igmm.ac.uk

GS Symposium6th May 2016

Caroline Hayward

Quantitative Trait Genetics in Health and DiseaseSlide2

20,032 GS:SFHS DNA samples genotyped and passed quality control with Illumina Omni-Express + Exome chip (at WTCRF Genetics Core lab, Edinburgh) (Ancestral outliers removed)

951,117 SNPs assayed, with low sample failure and high call rates870 DNAs that have been exome sequenced, primarily for analyses of depression and cognition or extremes of obesity;

family representatives, and parent-child trios & quads Funded by MRCHGU * and Wellcome

Trust (STRADL)**

*

**

*

Phase1* Phase2* Phase3**

Genotype

QC and SummariesSlide3

Efficient haplotype determinationSegregation of diseases and/or traits within families *Allow family-based linkage-type analyses Allow parent-of-origin analyses *

Enrichment for carriers of rare or novel variants Allow

de novo mutation discoveryHelps prediction and verification of sequence-identified variants (by imputation)

Value of Family data in

genome-wide genetic analysesSlide4

Genetic kinship annotated with self-reported Social PedigreeGenetic kinship annotated with corrected* Social Pedigree

P of sharing 0 alleles IBDP of sharing 1 alleles IBD

P of sharing 0 alleles IBD

P of sharing 1 alleles IBDTwins

Full Sibs

Parent-Child

Other related

Half Sibs

Unrelated

Social Pedigree Correction

*Corrections done by checking genetic relationships and questionnairesSlide5

Parent-childFull sibsHalf sibs

Cousins

Avuncular

Grandparent

9853

8495

381

2443

6599

848

Number genotyped

Males

Females

20032

8227

11805

Full Cohort

Pedigree size

Families

Family size

Generations

Average

Maximum

Average

Maximum

42662

6863

6

66

2.34

5

Genotyped IDs

Generation Scotland Family Summaries

Genotyped Pairs

(23960 without dummies)Slide6

Manhattan Plot GS 20K serum creatinineSLC34A1FBXO47Slide7

NASODIUM10974148254KPOTASSIUM10871

144156UREAUREA10859

140794CRE

CREATININE10853140103

eGFR

ESTIMATED GFR

10716

102709

eCOM

CKD Stage

10573

97539

CHOL

TOTAL CHOLESTEROL

10523

57594

HDL

HDL-CHOLESTEROL

10505

54371

CHR

TOTAL CHOL/HDL-CHOL

10496

55169

GLP

GLUCOSE (preserved tube)

10324

45257

Laboratory data on 10,943 unique Tayside participants was released by HIC to the Tayside Safe Haven for use by

GS (May 2014).

Increased to 11,125 participants (September 2015)

Baseline measures:

University of Dundee Health Informatics Centre (HIC)

Data ReleasesSlide8
Slide9

Uric acid data cleaning/selectionStandardise units to µmol/LSelect highest reading per IDRemove pregnant women (117)2,238 individuals with single measure collected from Oct 1988 to August 2015Date of test noted for age adjustment in association analysis.

Pilot study: Uric Acid from NHS biochemistry recordsSlide10

SLC2A9GWAS of Uric Acid from NHSSlide11

Research Collaborations

VIKING HEALTH STUDY

(Orkney & Shetland)

GENERATION SCOTLAND

(Scottish Family Health Study)

LOTHIAN BIRTH COHORTS

(1921 & 1936)

Scotland

IGMM

MRC HGU

CGEM

Usher Institute

Lynne Hocking, Alison Murray

(Aberdeen)

Blair Smith,

(Dundee)

Christian

Delles

, Ruth

Jarrett, Naveed Sattar

(Glasgow)

David

Porteous, Ian Deary

, Andrew McIntosh, Helen

Colhoun

(Edinburgh)

Viking Health Study

Lothian Birth Cohort

ROHgen

Ygen

LifeGen

UK

& Ireland

Martin

Tobin (Leicester

) SPIROMETA

Mark Iles (Leeds)

Mark

McCarthy,

Jonathan Marchini (Oxford)Tim Frayling (Exeter)CARTA Consortium (Bristol)UK BiobankSlide12

EUROPEUKEuropean Research Collaborations

EuropeIvana Kolcic, Tatijana

Zemonik,Ozren Polasek (Split, Croatia)

Yurii Aulchenko (Groningen, Netherlands)Olivier Devuyst, (Zurich, Switzerland)

Murielle Bochud , Zoltan Kutalik (Lausanne, Switzerland)

AGES Cohort,

Iceland

CROATIA-VIS

CROATIA-SPLIT

CROATIA -KORCULASlide13

UKEUROPEUSA

JAPANINDIA

AFRICA

CANADAWorldwide Research Collaborations

CHINA

INDONESIA

AUSTRALIA

Worldwide

CHARGE

CKDGEN

REPROGEN

Pfizer

CREAMSlide14

Publications resulting from GS dataSlide15

Thank youAll colleagues, collaborators and GS:SFHS participants